Nachrichten zur Hims & Hers Health Aktie

Hims & Hers shutters dermatology company it bought for $131 million

Apostrophes services were discontinued on March 7 and customers will be able to access their accounts "for the next 30…

Hims & Hers shutters Apostrophe in favor of its own tele-dermatology offerings

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify"…

Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would…

Why Hims & Hers Health Stock Just Popped

Roller-coaster healthcare stock Hims & Hers Health (NYSE: HIMS), whose stock got devastated last week by worries that it would…

Hims & Hers Health Aktie: FDA-Update könnte Kompoundierungsfrist ausdehnen

Charlotte (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von BofA Securities: Rating und Kursziel BofA hat das Kursziel für Hims & Hers Health…

Citi Sticks to Sell Rating on Hims & Hers (HIMS) Stock as FDA Ruling Clouds Outlook

Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims Hers Health ($HIMS) stock yesterday, citing increased…

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know

Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise…

Hims & Hers shutters dermatology business Apostrophe

The telehealth company acquired the personalised dermatology treatments player in 2021…

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is taking investors on a roller-coaster ride in 2025.…

BofA reiterates Hims & Hers stock underperform rating By Investing.com

BofA reiterates Hims & Hers stock underperform rating…

Should You Buy Hims & Hers Stock on the Dip?

Hims & Hers (NYSE: HIMS) is taking investors on a roller-coaster ride in 2025.…

Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.…

Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity? @themotleyfool #stocks $HIMS $LLY $NVO

Shutting down an acquisition caught investor attention, but theres more to the story.…

Jones Financial Companies Lllp Raises Stake in Hims & Hers Health, Inc. (NYSE:HIMS)

Jones Financial Companies Lllp boosted its holdings in Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 9.5% during…

Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?

Hims & Hers (NYSE: HIMS) stock is down 50% from its peak earlier this year, but the drop in shares…

Bay Area startup, a few years after being bought for $131M, shuts down

Hims and Hers closed the brand just weeks after a massive stock plunge.…

Citi maintains sell on Hims & Hers stock, target at $27 By Investing.com

Citi maintains sell on Hims & Hers stock, target at $27…

Hims & Hers Shuts Down Teledermatology Platform Apostrophe

Hims & Hers disclosed plans to shut down Apostrophe after buying the business for $190 million four years ago.…

Hims & Hers closed down Apostrophe, a skin care startup it bought four years ago

The company is shutting down the direct-to-consumer dermatology platform it bought for $190 million in 2021....…

Hims & Hers Stock (HIMS) Soars on Plans to Shutter Acne Treatment Unit

Hims Hers Health ($HIMS) has disclosed plans to shut down Apostrophe, its acne treatment business. This change is part…

Hims & Hers: AI-Powered Healthcare Disruption

…

Hims & Hers: AI-Powered Healthcare Disruption (NYSE:HIMS)

Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS…

Hims & Hers to Discontinue Dermatology Line Apostrophe

Apostrophe is folding back into Hims & Hers.…

Is Hims & Hers Health, Inc. (HIMS) the Best Skincare Stock to Buy According to Hedge Funds?

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article,…

Is Hims & Hers Health, Inc. (HIMS) the Best Skincare Stock to Buy According to Hedge Funds?

We recently compiled a list of the 10 Best Skincare Stocks to Buy According to Hedge Funds. In this article, we…

Major Stock Moves: Duke, Booking, Halliburton, Hims & Hers, Innovative

Insiders have been trading these 5 stocks: (($DUK)), (($BKNG)), (($HAL)), (($HIMS)) and (($IIPR)). Here is a breakdown of their recent…

Hims & Hers to shut down dermatology business Apostrophe

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday.…

Hims & Hers to shut down dermatology business Apostrophe By Reuters

Hims & Hers to shut down dermatology business Apostrophe…

Hims & Hers to shut down dermatology business Apostrophe

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. …

Hims & Hers to shut down dermatology business Apostrophe

Apostrophe is being shut down to "simplify its (companys) dermatology products and operations into one seamless experience," Hims & Hers…

Hims & Hers to shut down dermatology business Apostrophe

Apostrophe is being shut down to "simplify its (companys) dermatology products and operations into one seamless experience," Hims & Hers…

Hims & Hers to Shut Down Dermatology Business Apostrophe

(Reuters) -Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe…

Hims & Hers abandons dermatology business Apostrophe it paid $190M for

Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A…

Hims and Hers just shut down its dermatology business after stock slump on FDAs weight-loss drug decision

Hims and Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the…

Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.

Hims & Hers is shutting down its dermatology business, Business Insider has learned…

Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the…

Why Hims & Hers Health, Inc. (HIMS) Crashed on Thursday

We recently compiled a list of the 10 Stocks Drop Double Digits as Investor Caution Lingers. In this article, we are…

Why Hims & Hers Health, Inc. (HIMS) Crashed on Thursday

We recently compiled a list of the 10 Stocks Drop Double Digits as Investor Caution Lingers. In this article, we…

Hims & Hers: The Odds Are In Your Favor, Heres How To Take Advantage (Rating Upgrade)

…

Hims & Hers Stock: The Odds Are In Your Favor. Heres How To Take Advantage (NYSE:HIMS)

Hims & Hers Healths revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied…

Hims & Hers Aktie: Regulatorische Unsicherheiten als großes Risiko für Geschäftsmodell

New York (www.aktiencheck.de) - Hims & Hers-Aktienanalyse der Citigroup: 1. Überblick über die Situation Citigroup erwartet, dass die Aktien von Hims &…

This Could Be a Huge Blow to Hims & Hers Health Stock

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring…

Hims & Hers Health Faces Competitive and Regulatory Challenges Amid Novo Nordisk’s New Offering and FDA Developments

Michael Cherny, an analyst from Leerink Partners, reiterated the Hold rating on Hims & Hers Health (HIMS – Research Report).…

Director Sells Major Stake in Hims & Hers Health!

New insider activity at Hims & Hers Health ( ($HIMS) ) has taken place on March 7, 2025. Director Pendarvis…

Judge makes surprise ruling in weight-loss-drug case

The courts decision affects shares of Hims & Hers Health.…

Hims & Hers falls after a court ruling on a drug it never sold

The ruling on a drug similar to one Hims & Hers sold dims the hope that a judge could allow…

Hims and Hers at Morgan Stanley Conference: Strategic Growth Insights By Investing.com

Hims and Hers at Morgan Stanley Conference: Strategic Growth Insights…

Hims & Hers Health Aktie stürzt ab - FDA-Entscheidung belastet Geschäftsmodell

Frankfurt (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von XTB: Die Experten von XTB nehmen die Aktie von Hims & Hers Health,…

Why Hims & Hers Stock Just Collapsed

Hims & Hers Health (NYSE: HIMS) stock took a tumble Thursday morning, falling 9.2% through 11:40 a.m. ET on some…

Hims & Hers falls after US judge denies injunction on Zepbound copies

** Shares of telehealth firm Hims & Hers NYSE:HIMS fall 9% to $37.2 premarket ** A U.S. federal judge has…